Sponsored By

SupplySide West 20-Year Update: The Demise of Ephedra

The history of ephedra shows the only time FDA used regulation to ban an ingredient due to its unreasonable risk of illness or injury.

Steven Shapiro

April 5, 2016

1 Min Read
SupplySide West 20-Year Update: The Demise of Ephedra

From overtly enticing product marketing to highly publicized deaths allegedly linked to excess dietary supplement intake, ephedra caused a maelstrom that could have permanently crippled the industry. In retrospect, many marketers and product developers took note and raised the bar, helping mature the industry to what it is today.

About the Author(s)

Steven Shapiro

Steven Shapiro is a partner in the New York-based firm of Ullman, Shapiro & Ullman, LLP and has over 25 years of experience in food and drug regulatory matters and regularly counsels clients in the areas of food and drug law relating to the manufacture and marketing of foods, dietary supplements, drugs and cosmetics. He can be reached at 212-755-0299 or through the company’s website www.usulaw.com.


Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like